NIDDK is committed to transferring its technologies and research materials through collaborations with other organizations to benefit public health. If your organization has potential interest in a specific NIDDK technology or NIDDK technologies in a particular research area, please contact OTTD so we can explore possible opportunities with your organization.
NIH has a strong history and policy of encouraging the ease of availability of research materials, including compounds, proteins, antibodies, vectors, plasmids, knock-out and transgenic mice. We are pleased to be able to support the research of other investigators with our materials, and we appreciate receiving such material support from other organizations.
If you are interested in acquiring materials developed by NIDDK scientists for non-commercial research purposes conducted at universities or non-profit research organizations, these research resources are available under a material transfer agreement. Please view the Available Research Materials page to search our online materials catalog or for more information on obtaining a material transfer agreement.
If you are interested in discussing potential research collaboration opportunities, data sharing, unpublished research and materials, or future commercialization possibilities for a particular NIDDK technology with NIDDK scientists, please contact OTTD so that we facilitate the necessary arrangements, such as a confidentiality agreement, which will enable sharing or disclosing this information or identify an appropriate agreement that encourages knowledge sharing for a potential collaboration.
OTTD will facilitate arranging a mutually beneficial research agreement, for example, a Clinical Trial Agreement (CTA), a Cooperative Research and Development Agreement (CRADA), or a Research Collaboration Agreements (RCA) that maximizes innovation and collaboration for basic and clinical research, including investigator-initiated research and Phase I to Phase IV clinical trials, while protecting the intellectual property of both organizations.
For information on licensing materials for commercial research, please visit the central NIH Office of Technology Transfer website.
